Clinical Trial Update: Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating difluprednate for inflammation after cataract surgery in pediatric patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataracts
• Inflammation

Drugs mentioned

• Durezol (difluprednate)

Snippet

Sponsor: Alcon Research | Conditions: Cataracts, Inflammation | Phase 3 | Status: COMPLETED | Results posted: 2013-06-19